Shaping healthcare brand relationships
Over the past two decades Hall & Partners Health has helped shape the future of many of the world’s most successful pharmaceutical and healthcare brands.
We work with ambitious and inspiring clients and are proud to be long-term strategic partner of eight of the top ten biopharmaceutical companies. We also work with charities, start-ups, biotechs, device and diagnostic companies.
Our 100-strong specialised global health team uniquely combines strategic insight with lots of experience across different disease and healthcare disciplines.
Guiding principles to fit your brand
We recognise there is new thinking about how people build relationships with healthcare brands and services. Our guiding principles are informed by the latest thinking in behavioural economics and social science.
Cultural context and social influence are the primary drivers of behaviour. People’s primary response to brands and communications is instinctive and emotional, and building distinctive emotional connections drives your brand growth.
We consider every aspect of the customer experience, through what people…
To cut through, communications need to be DISTINCTIVE
People need to feel a strong instinctive emotional CONNECTION
People need to think there are some useful ADVANTAGES
You need to make things EASY for people to do
We have a strategic framework that describes how people experience and build relationships with healthcare brands. It enables you to plan, develop and optimise your marketing activity before, during and after purchase.
FRAME encourages creativity with disciplined thinking, allowing you to focus on the ways to strengthen engagement across your different audiences and drive growth.
Measuring the different dynamics of engagement helps you identify the actions needed to drive future sales and profitability.
This framework allows for the integration of brand evaluation and customer experience programmes with other data sources such as sales, social media and customer metrics, unlocking insights from previously unconnected sources of information.
We are experts in understanding people
Health is no longer viewed as one discrete component of life. It’s all-pervasive, as the boundaries between health and ‘living well every day’ become increasingly blurred.
That’s why it’s more important than ever to see the world from your customers’ perspective, understanding them as people, not just as patients, caregivers or healthcare professionals.
Clients are always coming to us with different challenges and we’re constantly inventing new ways to understand people, their emotions, instinctive decision-making and behaviours. We develop creative approaches by embracing new thinking, state-of-the-art technology and rich data sources.
Our strategic planning cycle tackles the toughest brand and marketing challenges, determining where you are in your brand lifecycle and identifying the questions that you want answered.
WHERE ARE YOU NOW?
WHERE DO YOU WANT TO BE?
What is the organisation's defining goal and purpose?
What are the commercial goals and objectives?
What behaviours are you trying to change?
What is the brand vision, proposition and distinctive assets?
Brand and Communications Tracking
HOW DO YOU GET THERE?
ARE YOU GETTING THERE?
How is the brand performing against commercial goals (Do Goals) and is its strategy reflected in the 'Engagement Plan'?
How can you optimise your marketing activity and investment?
How will these changes impact on market performance?
Co-creative Idea Development
Big Idea Testing
ONCOLOGY CENTRE OF EXCELLENCE
Our team of strategists and insight specialists has years of experience and expertise across solid and hematological tumour types.
Using our in-depth knowledge of the oncology landscape and evolving dynamics, we're comfortable engaging with all types of oncology customers to uncover meaningful insight. Through our intimate understanding of behavioural economics we turn insight into strategic and actionable outputs.
Our expertise spans the lifecycle of oncology drugs from early phase development to commercialisation. This includes identifying necessary trial endpoints that make a clear difference, through to developing a distinct brand and creating compelling marketing material.
We work with many of the world’s largest pharmaceutical, healthcare and technology brands across a wide range of therapy areas and sectors, including (but not limited to):
General medicines Cardiovascular and metabolic, autoimmune and inflammation, gastrointestinal, respiratory
Oncology Breast, colorectal, lung, cervical, prostate, ovarian, pancreatic, renal, hepatic, glioblastoma, squamous cell, lymphoma, leukemia, multiple myeloma, melanoma, GIST, myelofibrosis, bone metastases
Vaccines Human papillomavirus, herpes zoster, hepatitis A and B, rotavirus, pneumococcal, influenza, pertussis, Dengue, meningococcal, tetanus
Neuroscience Alzheimer’s disease, attention deficit disorder, migraine, fibromyalgia, multiple sclerosis, depression, Parkinson’s disease, epilepsy, schizophrenia
Infectious diseases Hepatitis, HIV, carbapenem-resistant gram-negative infections, gram-negative and positive infections including C. difficile, complicated UTIs, complicated IAIs, ABSSSI and MRSA
Rare diseases Fabry disease, familial chylomicronemia syndrome, cystic fibrosis, growth hormone disorders, IPF, rare tumours including neuroendocrine tumours, Cushing’s disease, pulmonary arterial hypertension, Gaucher disease
Consumer health OTC medicines, smoking cessation, contraception, incontinence, dental, cosmeceuticals, eye care, pain management, allergies, wellness
Devices and diagnostics Connected devices, blood glucose monitors, inhalers, apps